46 results about "Buddleja asiatica" patented technology

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to traditional Chinese medicine emulsifiable paste for treating pruritus cutanea after hematodialysis. The traditional Chinese medicine emulsifiable paste is prepared from the following traditional Chinese medicine raw materials in parts by weight: 1-2 parts of naoyu millettia, 2-3 parts of buddleja asiatica, 3-5 parts of syzygium samarangense roots, 3-5 parts of sapium discolor roots, 2-4 parts of small-leaved lemmaphyllum, 6-9 parts of shiangshitianluo, 3-5 parts of fructus kochiae, 3-5 parts of acanthopanax ricinifliux seem roots, 3-5 parts of folium artemisiae argyi, 3-5 parts of blumea megacephala, 3-5 parts of blumea, 2-3 parts of pteris semipinnata and 2-4 parts of yellow chinaberry trees. The traditional Chinese medicine raw materials are combined to achieve the effects of clearing away heat and toxic materials, dispelling wind and arresting itching. The traditional Chinese medicine emulsifiable paste is remarkable in effect in treating pruritus cutanea after hematodialysis, safe and free of toxic or side effects, and capable of improving the living quality of the hemodialysis patient.

The invention discloses a traditional Chinese medicine preparation for treating scapulohumeral periarthritis and a preparation method of the traditional Chinese medicine preparation, and belongs to the field of traditional Chinese medicine. The effective ingredients of the traditional Chinese medicine consist of the following raw materials: fiddleleaf fig root leaf, smilax riparia, pine nodes, hypericum uralum, chicken girt, rhizoma dioscoreae nipponicae, urtica cannabina, Canton fairybells root and rhizome, radix angelicae pubescentis, concha arcae, sinapis semina, velvety clovershrub root, wilson passionflower herb, large-leaved gentian, buddleja asiatica and angelica sinensis. The medicinal materials for preparing the traditional Chinese medicine preparation are appropriately combined, accord with traditional Chinese medicinal and modern medicinal theories, and have the effects of promoting blood circulation to remove meridian obstruction, relaxing muscles and tendons to relieve pain, promoting qi to activate blood, relieving hyperacidity and relieving pain. The traditional Chinese medicine preparation is convenient to use, and has good absorption effect and no adverse, toxic or side effect. Clinical verification proves that the traditional Chinese medicine preparation has an extremely good effect on prevention and treatment of scapulohumeral periarthritis, and is applicable to prevention and treatment of scapulohumeral periarthritis.

The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine for treating ischemic necrosis of femoral head. The traditional Chinese medicine for treating ischemic necrosis of femoral head is prepared from the following raw materials: cornu cervi, herba cistanche, resina draconis, frankincense, myrrh, salviae miltiorrhizae, flowers carthami, radix achyranthis bidentatae, eucommia ulmoides, woodwardia japonica, drynaria rhizome, schisandra chinensis, astragalus membranaceus, Chinese yam, angelica sinensis, radix rehmanniae preparata, costustoot, poria cocos, loranthus parasiticus, liquorice, notopterygium, radix clematidis, buddleja asiatica, ligularia japonica, cuneate lespedeza herb with root, common calanthe herb and herba inulae. According to the traditional Chinese medicine, the adopted medicinal materials are in supplement with each other; the traditional Chinese medicine is prepared by the theoretical composition of the traditional Chinese medicine according to a certain weight ratio, has a significant curative effect on treatment of ischemic necrosis of femoral head, and is abundant in raw material source, moderate in price, simple in process and easy to accept by patients; the pain of aches and limitation of motion of patients can be relieved or even avoided; the diseases are treated; the constitution of patients can be enhanced; and health is promoted.

The invention discloses a traditional Chinese medicine preparation for fracture nursing and a preparation method thereof, belonging to the field of traditional Chinese medicines. The traditional Chinese medicine preparation comprises the effective constituents of radix paeoniae rubra, hypericum japonicum, common yellow oxalis herb, root and rhizome of canton fairybells, buddleja asiatica, zanthoxylum dissitum, hongkong rhaphidophora stem, radix dipsaci, cortex albiziae, herba barleriae lupulinae, orobanche coerulescens, eucommia ulmoides, folium eucalypti, corn cervi pantotrichum, Japanese coniogramme rhizome herb and marsdenia longipes. The traditional Chinese medicine preparation accords with the theories of the traditional Chinese medicine and pharmacy and the modern medicine and pharmacology as the medicinal materials are compatible appropriately, has the efficacies of promoting blood circulation to arrest pain, strengthening tendons and bones, clearing away heat for detumescence and promoting coronary circulation, is convenient to use, good in absorption effect and free of toxic and side effects, is clinically proved to have extremely good effect for the recovery and union of fractured limbs and is suitable for the clinic treatment and nursing of fracture as well as popularization and application.

The invention relates to a pharmaceutical composition for treatment of varicosity and a preparation method thereof. The pharmaceutical composition comprises 3-80 parts of saffron crocus by weight, 3-80 parts of olibanum by weight, 3-80 parts of myrrh by weight, 3-60 parts of radix rehmanniae by weight, 3-60 parts of radix sophorae flavescentis by weight, 6-100 parts of sangusis draconis by weight, 6-100 parts of leech by weight, 3-80 parts of leonurus by weight, 3-80 parts of waxgourd peel by weight, 3-100 parts of eupolyphaga by weight, 80-200 parts of murraya paniculata by weight, 3-80 parts of ligusticum wallichii by weight, 3-80 parts of pyrola by weight, 3-50 parts of teucrium viscidum by weight, 3-60 parts of curcuma zedoary by weight, 1-30 parts of madder, 30-80 parts of buddleja asiatica by weight, 3-60 parts of radix angelicae pubescentis by weight, 3-60 parts of cinnamon by weight, 3-100 parts of lysimachia nummularia by weight, 3-100 parts of tetrapanax papyriferus by weight, 3-80 parts of codonopsis pilosula by weight, 3-30 parts of angelica sinensis by weight, 1-30 parts of pseudo-ginseng and optional pharmaceutically acceptable excipients.

The invention relates to a traditional Chinese medicine for treating cholestatic hepatitis. The traditional Chinese medicine for treating the cholestatic hepatitis is prepared from the following medicinal materials in parts by weight: 14 parts of piper cubeba, 12 parts of elsholtzia, 8 parts of Himalayan horsegentian herb, 10 parts of melilot, 14 parts of pleione saxicola, 14 parts of lacebark pine cone, 16 parts of bodinier caper, 8 parts of altingia chingii metc., 14 parts of auricled hedyotis herb, 13 parts of cantonese speranskia, 16 parts of tamarindus, 15 parts of coriaria sinica, 12 parts of buddleja asiatica, 14 parts of combretum leaf, 8 parts of hemiboea subcapitata, 10 parts of codonopsis convolvulacea and 12 parts of lowdaphne stringbush flower and leaf. A clinical experiment proves that the traditional Chinese medicine for treating the cholestatic hepatitis can be used for safely and effectively treating the cholestatic hepatitis.

A pharmaceutical composition for treating liver cirrhosis is provided; the pharmaceutical composition is composed of the pharmaceutical raw materials: vervain, adenophora stricta miq., liquorice, radix sanguisorbae, sanguis draxonis, polygonum cuspidatum, fructus ligustri lucidi, rhizoma corydalis, wild buckwheat, rhizoma imperatae, spica prunellae, akebia stem, radix gentianae macrophyllae, erythrina variegata, endothelium corneum gigeriae galli, dandelion, capillary artemisia, rhizoma ligustici wallichii, roughhaired holly, safflower, herba lysimachiae, rhizoma sparganii, buddleja asiatica, piper hancei, kadsura pepper stem, barbed skullcap herb, pseudo-ginseng, spreading hedyotis herb, rhizoma gastrodiae, phyllanthus urinaria, agastache rugosus, gynostemma pentaphylla, fructus liquidambaris and cassia twig. The drug components in the combination are cooperative with each other, together play effects of clearing away heat and detoxifying, soothing liver and regulating circulation of qi, and promoting blood circulation to remove blood stasis, and have obvious effects in use for improving the living quality of patients with liver cirrhosis.

The invention discloses a mecodium badium and rutin compound nursing medicament for treating skin injury. The medicament mainly comprises traditional Chinese medicine components and Western medicine components, wherein the traditional Chinese medicine components are prepared from mecodium badium as a main material and the following traditional Chinese medicines as auxiliary materials through extraction: wood of true lacquertree, coriolus hirsutus, root of actinidia, root of phyllodium pulchellum, piper yunnanense Tseng, eritrichium pectinatum, cipedessa cinerascens, sabina chinensis, lagochilus lanatonodus, caesalpinia decapetala, omei mountain bambusa, euonymus hamiltonianus, colebrookea oppositi folia Smith, pyrus betulaefolia (bark), buddleja asiatica, ajuga forrestii Diels and oxystelma esculentum; the Western medicine components comprise rutin, silk polypeptide, glycosaminoglycan, tocopherol, fibronectin, lignin, L-proline and histidine. The nursing medicament has the effects of removing toxicity, clearing heat, promoting granulation, stopping bleeding, promoting qi to activate blood, dehumidifying, diminishing swelling, and preventing tumor, has good effects of preventing oxidation and removing free radicals, promotes regeneration of tissue cells, and enhances the immunity of the human body; the treatment from inside to outside is realized, so that the defect that the conventional external use medicament cures the symptoms, but cannot cure the diseases is overcome.

Disclosed is a traditional Chinese medicine combination for treating itchy skin after hemodialysis. The active pharmaceutical ingredients of the traditional Chinese medicine include Blumea megacephala, Japanese coniogramme rhizome, Tribulus terrestris, Chinese lizardtail rhizome, Eucommia bark, Buddleja asiatica, northern radix sileris, feather cockscomb seed, Sapium discolor root, multiflower knotweed vine, Scutellaria indica, gentian root, oriental wormwood, human placenta, Paris polyphylla, cnidium fruit, paniculate swallowwort root, parslane herb, mint, Rhizoma fagopyri cymosi, Chinese angelica root, giant knotweed rhizome, indigowoad leaf, sophora flower bud, astragalus root, Ventilago leiocarpa benth, Solanum vine, cicada shell and licorice root. The traditional Chinese medicine combination has medicine compatibility, thereby having efficacies of activating and nourishing blood, clearing heat and removing toxicity and dispelling wind and stopping itching; the traditional Chinese medicine combination has a remarkable treatment effect in itching after renal dialysis and is safe and free of toxic and side effects; and with the traditional Chinese medicine combination, the living quality of a patient after going through renal dialysis can be improved remarkably.

The invention discloses a traditional Chinese medicine for treating prostatic hyperplasia. The traditional Chinese medicine is prepared by decocting stems of arcangelisia loureiri, herb of sticky adenosma, herb of urtica fissa Pritz., rhizoma nardostachyos, buddleja asiatica herb, herba selaginellae doederleinii, radix paeoniae alba, herba lysionti, tubers of stachys geobombycis and water according to a certain proportion. By adopting multiple Chinese herbs for cooperation, the traditional Chinese medicine has the effects of removing blood stasis to eliminate stagnation, promoting urination and promoting blood circulation to relieve swelling, can effectively treat the prostatic hyperplasia and is free of toxic and side effects.

The invention discloses a method for extracting Budiaoside A from Buddleja. The method steps are as follows: take Buddleia and grind it into 40-80 meshes, add it to a supercritical extraction kettle, perform gradient extraction with supercritical CO2 under the environment of extraction pressure 15-30MPa and temperature 40-50°C, analyze the extract, and collect the effective extract Reagent for material recovery, the resulting extract is dissolved in hot water, polyamide resin is added for adsorption, ethanol aqueous solution gradient elution, the active ingredients are collected and concentrated under reduced pressure, the concentrated solution crystallizes, the crystals are filtered out, dissolved in ethanol for recrystallization, and dried to obtain Buddleia Glycoside A. The method adopted in the invention has high extraction efficiency, low energy consumption, little pollution, simple process steps and is suitable for industrialized production.

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine for treating gynecological postoperative lumbar pain due to qi stagnation and blood stasis. The composition is prepared from the following traditional Chinese medicinal materials in parts by weight: 5-13 parts of buddleja asiatica, 5-13 parts of plumbago zeylanica, 4-8 parts of marsdenia longipes, 4-8 parts of radix pterospermi heterophylli, 4-8 parts of sargentgloryvine stem, 4-8 parts of ramulus euonyrni, 4-8 parts of artemisia anomala, 4-8 parts of fortunella cargarita, 4-8 parts of russula virescens and 4-8 parts of licorice root. The medicinal materials are combined to achieve the effects of promoting circulation of qi and blood to remove stasis and relieving pain, and is closely related with the etiology and pathogenesis of gynecological postoperative lumbar pain due to qi stagnation and blood stasis. The traditional Chinese medicine composition can be used for remarkably relieving patient pains and has a remarkable clinical curative effect.

The invention relates to a traditional Chinese medicine for treating henoch-schonlein purpura nephritis. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 16 parts of trema cannabina, 14 parts of eurya groffii merr leaves, 14 parts of phyllostachys viridis, 12 parts of urtica laetevirens, 15 parts of syringa velutina, 15 parts of merremia hungaiensis, 10 parts of tripterygium glycosides, 14 parts of lysimachia fortunei maxim, 14 parts of polygonatum punctatum royle, 10 parts of many-nerved bauhinia leaves, 12 parts of trifoliate acanthopanax twig leaves, 10 parts of coriaria sinica maxim, 16 parts of swertia kauitchensis franch, 8 parts of auricled hedyotis herbs, 8 parts of lowdaphne stringbush flower, 14 parts of stizolobium Cochinchinesis, 18 parts of rubiaceae randia depauperata, 12 parts of polymorpha, 10 parts of stegnogramma cyrtomioides, 8 parts of buddleja asiatica, 10 parts of autumn zephyrlily herb and 8 parts of agalloch eaglewood. The traditional Chinese medicine can safely and effectively treat the henoch-schonlein purpura nephritis.

The invention relates to the field of pharmaceutical formulation, in particular to a traditional Chinese medicine for treating itching caused by liver diseases. The traditional Chinese medicine is characterized by being prepared from the following raw medicinal materials in parts by weight: 17 to 22 parts of caesalpinia minax, 13 to 17 parts of buddleja asiatica, 17 to 22 parts of convolvulus arvensis, 3 to 7 parts of viburnum dilatatum, 13 to 17 parts of radix ampelopsis, 17 to 22 parts of ageratum conyzoides, 17 to 22 parts of galium aparine, 13 to 17 parts of root of kalopanax septemlobus, 17 to 22 parts of centella asiatica, 22 to 28 parts of oroxylum indicum, 13 to 17 parts of solanum surattense, 3 to 7 parts of ophiopogon japonicus, 13 to 17 parts of tribulus terrestris, 8 to 12 parts of bougainvillea spectabilis, 8 to 12 parts of chaulmoogra, 5 to 12 parts of rubus pirifolius, 13 to 17 parts of dried root of sambucus chinensis, 8 to 12 parts of herba aristolochiae, 8 to 12 parts of vitex trifolia and 17 to 22 parts of herminium monorchis. The preparation method includes the following steps: soaking the raw medicinal materials in water, decocting and then removing the slag to obtain the filtrate.

The invention discloses a formula of a traditional Chinese medicine for treating bone fracture and a preparation method thereof. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 9g of buddleja asiatica, 5g of iris confusa, 10g of diplopterygium laevissimum, 15g of glabrous sarcandra glabrous herb, 12g of three-leaf tea, 10g of chicken blood, 10g of allium prattii, 15g of fordia cauliflora, 10g of maesa perlarius, 12g of lodestone, 25g of munronia delavayi, 10g of araliaceae acanthopanax trifoliatus, 12g of trachelospermum jasminoides, 5g of rhizoma coptidis and 10g of pentapanax yunnanensis. The traditional Chinese medicine is convenient to use, low in cost and obvious in efficacy, and cannot generate side effects. After the traditional Chinese medicine is used for 15 days, a patient can move normally; and the potential danger is not generated when the traditional Chinese medicine is taken by the patient.

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating primary PCI (percutaneous coronary intervention) postoperative poor myocardial perfusion of patients suffering from heart-qi deficiency type ST-segment elevation myocardial infarction. The traditional Chinese medicine composition which is a traditional Chinese medicine comprises, by weight, 4-8 parts of nigella damascena, 4-8 parts of herba alyxiae sinensis, 4-8 parts of Phlegmariurushamiltonii (Spreng.) LoveetLovevar. petiolatus (Clarke) Ching, 4-8 parts of fructus psoraleae, 4-8 parts of semen ginkgo roots, 2-4 parts of meconopsis horridula, 4-8 parts of radix paeoniae alba, 4-8 parts of buddleja asiatica, 4-8 parts of plumbago indica and 4-8 parts of radix glycyrrhizae. The traditional Chinese medicine composition has the advantages that various medicines are used with one another, and accordingly effects of 'nourishing heart-qi and agitating heart vessels' can be jointly realized; myocardial perfusion of the patients suffering from the primary PCI postoperative poor myocardial perfusion and the STEMI (ST-segment elevation myocardial infarction) can be obviously improved.

The invention relates to a plaster for treating traumatic injuries, which is prepared from the following raw materials in parts by weight: 40-50 parts of ophicalcite, 25-30 parts of ground beetle, 90-100 parts of goat blood (yimayin-chisu), 40-50 parts of leech, 100-115 parts of trogopterus dung, 30-35 parts of chloranthus holostegius, 70-80 parts of buddleja asiatica, 50-70 parts of Indian strawberry, 30-40 parts of crowfoot, 45-55 parts of ardisia crispa, 30-40 parts of safflower, 90-110 parts of logwood, 90-100 parts of peach kernel, 50-55 parts of dioscorea nipponica, 50-70 parts of garden balsam stem, 35-40 parts of moutan bark, 180-190 parts of white vinegar, 230-245 parts of vaseline and 70-90 parts of honey. According to the invention, medicinal materials with different properties are combined scientifically, and all medicines play roles in promoting blood circulation to remove blood stasis, promoting reunion of fractured bones, breaking blood to expel stasis as well as eliminating swelling and alleviating pain. The plaster has an effective rate of more than 91% when used for treating traumatic injuries, thereby achieving a relatively good clinical curative effect.

The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicine composition for treating phlegm-turbidity blocking type STEMI (St-elevation myocardial infarction) direct PCI (percutaneous coronary interention) postoperative myocardial perfusion deficiency. The traditional Chinese medicine composition is prepared from the following ingredients in parts by weight: 2 to 4 parts of semen brassicae, 4 to 8 parts of acorus gramineus soland, 4 to 8 parts of Chinese alyxia herb, 4 to 8 parts of Bagusheng, 4 to 8 parts of dysosma versipellis, 4 to 8 parts of paeonia lactiflora, 4 to 8 parts of buddleja asiatica, 4 to 8 parts of plumbago indica and 4 to 8 parts of liquorice. All medicine is used and matched together for achieving the effects of eliminating phlegm for resuscitation, activating blood and dredging collaterals. The myocardial perfusion of a patient with STEMI direct PCI postoperative myocardial perfusion deficiency can be obviously improved.

The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicine composition for treating residual stones (caused by a heat-damp syndrome) after percutaneous nephrolithotomy of lithangiuria. The traditional Chinese medicine composition comprises the following Chinese herbs by weight: 4 to 13 parts of leaf of delavey greenleaf elaeagnus, 4 to 13 parts of linaria buriatica Tarcz.et Benth., 4 to 13 parts of amaranthus lividus s L., 4 to 8 parts of buddleja asiatica, 4 to 8 parts of leaf of manynerve bauhinia, and 4 to 8 parts of liquorice. All the Chinese herbs are used together to play the effects of clearing heat and promoting diuresis, treating stranguria to discharge stones, promoting qi to activate blood circulation and dissipate blood stasis, and invigorating kidney qi, and are highly close to the pathogenesis of the residual stones (caused by the heat-damp syndrome) after percutaneous nephrolithotomy of lithangiuria, so that the traditional Chinese medicine composition has the advantages that postoperative residual stones can be discharged effectively and fast; the taking is safe; no obvious adverse reaction is caused.

The invention discloses a traditional Chinese medicine patch for treating osseous rheumatism and a preparation method thereof. The traditional Chinese medicine patch is prepared from Chinese herbal medicine and auxiliary materials, wherein the Chinese herbal medicine comprises, by weight, 8 g of rhizoma dioscoreae nipponicae, 8 g of caesalpinia cucullata, 8 g of clematis argentilucida, 6 g of scorpions, 6 g of buddleja asiatica, 10 g of stellaria saxatilis buch.-ham.[s. vestita kurz], 8 g of prepared kusnezoff monkshood roots, 10 g of hemsley monkshood roots, 8 g of neocinnamomum poilanei h. liou, 8 g of whitewood, 5 g of Chinese silkvine root-bark, 8 g of common bluebeard herbs, 6 g of parish's ironweed, 6 g of tarenna attenuata (voigt) hutch and 6 g of radix angelicae; the auxiliary materials comprise, by weight, 200 g of sesame oil and 200 g of yellow lead. The traditional Chinese medicine patch can achieve the effects of dispelling wind, eliminating dampness, relaxing muscles and tendons, promoting blood circulation and relieving pain, when the traditional Chinese medicine patch is used for treating osseous rheumatism, no side effect is caused, the recurrence rate is low, and the pharmacological effect is remarkable.

The invention relates to a health preservation foot bath medicine recipe as well as a preparation method and application thereof. The health preservation foot bath medicine recipe comprises traditional Chinese medicine materials of radix buddlejae asiaticae, radix sophorae flavescentis, radix astragali, radix sileris, herba siphonostegiae chinensis, folium artemisiae, garlic stems and loofah sponge according to the medicine use ratio of 20:10:20:10:5:20:5:10. The preparation method comprises the following steps of grinding each raw material ingredient into powder; proportionally mixing the rawmaterial ingredients; using non-woven cloth bags for split charging; performing hot sealing on the cloth bags to obtain the health preservation foot bath medicine recipe. According to a use method, the health preservation foot bath medicine recipe is soaked for 3 to 5 min by boiling water or is decorated and boiled for 5 to 8 min by open fire; then, the medicine is used for hand and foot soakingor medicine bath. The foot bath medicine recipe provided by the invention has the excellent effects of dispelling the wind, dispelling cold, clearing away heat, killing parasite and eliminating toxin,and is a foot bath medicine recipe suitable for all people groups with any physical signs to use; the recipe is suitable for health preservation; the symptoms of fatigue, insomnia, detoxication, lumbocrural and ischiadic nerve pain, eczema, onychomycosis, tinea manus and pedis, acrohyperhidrosis, foot odor, foot rhagadia, callus and the like can be effectively eliminated.

The invention discloses a traditional Chinese medicine preparation for treating tuberculous pleuritis. The traditional Chinese medicine preparation for treating tuberculous pleuritis disclosed by the invention is prepared from the following traditional Chinese medicines in parts by weight: 10-15 parts of frangrant ainsliaea herb, 10-18 parts of aletris spicata, 5-10 parts of galangal, 3-5 parts of alpinia oxyphylla, 15-22 parts of ardisia japonica, 10-18 parts of przewalskii, 12-18 parts of arisaema asperatum, 15-20 parts of radix asparagi, 5-8 parts of amur barberry root, 4-8 parts of rhizoma bletillae genus, 8-15 parts of boerhavia diffusa, 10-12 parts of brachystelma edule, 2-4 parts of buddleja asiatica and 3-8 parts of codonopsis lancifolia. According to dialectical theories of traditional Chinese medicines, the traditional Chinese medicine preparation for treating tuberculous pleuritis disclosed by the invention has the benefits that the formula is simple, materials are easily available, cost is low, the curative effect is high and no any toxic or side effect is caused. The traditional Chinese medicine preparation has the effects of regulating the flow of vital energy, dredging collaterals, reducing phlegm, invigorating the circulation of blood, nourishing yin and clearing heat; and therefore, the traditional Chinese medicine preparation for treating tuberculous pleuritis disclosed by the invention has curative effects for all patients and has broad-spectrum practicability.

The invention belongs to the technical field of medicines, and in particular relates to a traditional Chinese medicine composition for treating poor heart muscle perfusion after a direct PCI surgery of heart-yang inactivation type ST-elevated myocardial infarction (STEMI). The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines in parts by weight: 5 to 13 parts of arisaema fargesii buchet, 4 to 8 parts of herba alyxiae sinensis, 4 to 8 parts of phlegmariurus hamiltonii, 4 to 8 parts of psoralea corylifolia, 4 to 8 parts of ginkgo biloba, 2 to 4 parts of meconopsis horridula, 4 to 8 parts of debark peony root, 4 to 8 parts of buddleja asiatica, 4 to 8 parts of plumbago indica and 4 to 8 parts of liquorice root. Various medicines are jointly used to achieve the efficacy of tonifying yang and activating heart-yang. The poor heart muscle perfusion of a patient after the direct PCI surgery of STEMI can be obviously improved.

The invention discloses traditional Chinese medicine decoction for treating arthritis and a preparation method for the traditional Chinese medicine decoction. The traditional Chinese medicine decoction is prepared from the following raw materials in parts by weight: 30 to 35 parts of munronia henryi harms, 12 to 15 parts of fmoes officinalis ames, 20 to 25 parts of croton seed, 10 to 15 parts of rosamultiflora, 22 to 25 parts of semiliquidambar cathayensis, 20 to 25 parts of conespike flemingia root, 15 to 20 parts of wilson's passion flower, 10 to 15 parts of puberulent premna leaf or root, 8 to 10 parts of chinaroot greenbrier, 2 to 5 parts of kirilow groundsel herb, 2 to 3 parts of enemion raddeanum, 15 to 18 parts of buddleja asiatica, 8 to 12 parts of stachys sieboldii miq., 1 to 2 parts of veined inula root, 4 to 8 parts of litsea rotundifolia and 3 to 5 parts of luisia morsei. The traditional Chinese medicine decoction for treating arthritis has a good treatment effect and short treatment time, is capable of reducing pain of a patient, and has no side effect.

The invention discloses an external fumigation-washing traditional Chinese medicine for treating traumatic soft tissue ossification and calcification. The external fumigation-washing traditional Chinese medicine has an optimal prescription by weight as follows: 150g of alangium platanifolium, 50g of oblongleaf kadsura stem root, 60g of lycopodium clavatum, 50g of citronella, 5g of daemonorops draco, 55g of sargentgloryvine stem, 100g of premna fulva craib, 55g of buddleja asiatica, 50g of elderberry, and 50g of rhizoma nardostachyos. Medicines in the prescription are divided into crude medicines and processed medicines which are strictly processed to reach a preset efficacy standard and then are integrally grinded into thick powders, and the thick powders are bagged for external use in a fumigation-washing mode only, not for drinking. A patient being subjected to traumatic soft tissue ossification and calcification can be treated with the external fumigation-washing traditional Chinese medicine in a pore penetrating fumigation-washing mode for 30 minutes once and twice each day; and after being used, the external fumigation-washing traditional Chinese medicine can be stored in an original container for next use by being heated. The external fumigation-washing traditional Chinese medicine in the bag can be repeatedly used at three times, and fifteen days are considered as a course. The external fumigation-washing traditional Chinese medicine has no any toxic and side effects and is obvious in curative effect.